# Anti-inflammatory H1 Antihistamines Allergic Rhinitis

> **NCT02507635** · PHASE4 · COMPLETED · sponsor: **Iuliu Hatieganu University of Medicine and Pharmacy** · enrollment: 115 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Levocetirizine
- **DRUG:** Desloratadine

## Key facts

- **NCT ID:** NCT02507635
- **Lead sponsor:** Iuliu Hatieganu University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-11
- **Final completion:** 2013-05
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2015-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02507635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02507635, "Anti-inflammatory H1 Antihistamines Allergic Rhinitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02507635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*